Cupino, Melanie .
HRN: 22-85-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2023
CEFTRIAXONE 1G (VIAL)
12/20/2023
12/20/2023
IV
1 Gram
Q12
CAP-MR ; BAIAE; G3P1 (1011) 25 6/7 Weeks AOG
Waiting Final Action
Indication: Prophylaxis Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes